Seller record · Telehealth service

Ryze Rx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 5 of 8 criteria. S2, prescription gating: Each product page sells the prescription by vial strength at a listed price with an add-to-cart button, and the home page lists every medication with an add button. The steps page describes a health questionnaire first, but the product pages put the medication in a cart. 4 more criteria also fail; see the table below.

At a glance

Ryze RxTelehealth service

3/8criteria passed

Price: Compounded semaglutide from $119 for a 1 mg vial; tirzepatide from $199 for a 5 mg vial
Sells: compounded semaglutide, compounded tirzepatide, and 11 more
FDA letters: None on file

Visit Ryze Rx See all eight dispositions

Telehealth service. Passes 3 of 8 criteria. Recorded against Standard v1.1.

A telehealth storefront selling compounded semaglutide and tirzepatide by the vial, testosterone, and a peptide line that includes BPC-157, sermorelin, NAD+, GHK-Cu, MOTS-C and epithalon, each priced with an add-to-cart button. It prints a company name and a city but no street address, and names no pharmacy or prescriber.

Operating entity Ryze RX LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Ryze Rx's how it works page; Ryze Rx's terms
S2	Prescription gating	FAIL	Ryze Rx's injectable semaglutide product page; Ryze Rx's injectable tirzepatide product page; Ryze Rx's website; Ryze Rx's how it works page
S3	Pharmacy identification	FAIL	Ryze Rx's injectable semaglutide product page; Ryze Rx's about page; Ryze Rx's terms
S4	Compounding disclosure	FAIL	Ryze Rx's injectable semaglutide product page; Ryze Rx's about page; Ryze Rx's weight loss page
S5	Analytical documentation	FAIL	Ryze Rx's about page; Ryze Rx's BPC-157 product page
S6	Business address	FAIL	Ryze Rx's contact page; Ryze Rx's terms; Ryze Rx's privacy page
S7	Price disclosure	PASS	Ryze Rx's injectable semaglutide product page; Ryze Rx's injectable tirzepatide product page; Ryze Rx's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified physician licensed in the patient's state reviews each health questionnaire within 24 hours and prescribes, and the terms say every treatment decision is made by the reviewing clinician. No prescriber is named.Source: Ryze Rx's how it works page; Ryze Rx's terms.

S2FAILEach product page sells the prescription by vial strength at a listed price with an add-to-cart button, and the home page lists every medication with an add button. The steps page describes a health questionnaire first, but the product pages put the medication in a cart.Source: Ryze Rx's injectable semaglutide product page; Ryze Rx's injectable tirzepatide product page; Ryze Rx's website; Ryze Rx's how it works page.

S3FAILNo filling pharmacy is named. The product page answer to where the medication is compounded says only that licensed US 503A and 503B compounding pharmacies dispense every medication, and the about page, terms and privacy policy name none.Source: Ryze Rx's injectable semaglutide product page; Ryze Rx's about page; Ryze Rx's terms.

S4FAILNo page states that the compounded semaglutide, tirzepatide or peptides are not FDA-approved. The product pages describe the pharmacies as FDA-regulated and FDA-registered and sell the medications with no approval statement.Source: Ryze Rx's injectable semaglutide product page; Ryze Rx's about page; Ryze Rx's weight loss page.

S5FAILNo certificate of analysis or lot document is published. The about page says the medications are third-party tested for purity and potency, with no report behind the claim.Source: Ryze Rx's about page; Ryze Rx's BPC-157 product page.

S6FAILNo street address appears on the contact page, in the terms or in the privacy policy, which name Ryze RX LLC and give only Austin, Texas, an email address and a telephone number.Source: Ryze Rx's contact page; Ryze Rx's terms; Ryze Rx's privacy page.

S7PASSCompounded semaglutide from $119 for a 1 mg vial to $219 for a 10 mg vial, and compounded tirzepatide from $199 for a 5 mg vial to $359 for a 30 mg vial, or $499 and $799 for 3-month kits. BPC-157, sermorelin, NAD+, MOTS-C and GHK-Cu at $249, epithalon, LL-37, DSIP and 5-Amino at $199, and glutathione at $179. The banner gives GLP-1s from $119 a month while the treatments grid gives weight loss from $149 a month.Source: Ryze Rx's injectable semaglutide product page; Ryze Rx's injectable tirzepatide product page; Ryze Rx's website.

S8PASSNo FDA warning letter names Ryze Rx or Ryze RX LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, testosterone replacement therapy, sermorelin, BPC-157, NAD+, glutathione, MOTS-C, GHK-Cu, epithalon, LL-37, DSIP, 5-Amino.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells GHK-Cu Who sells BPC-157 Who sells MOTS-c Who sells epitalon

Visit Ryze Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.